Chondroblastoma: Is intralesional curettage with the use of adjuvants a sufficient way of therapy?

BACKGROUND: Chondroblastoma is a rare benign cartilaginous bone tumor that represents 1–2% of all primary bone tumors. It is characterized by aggressive growth, possible recurrence after surgical treatment and, in rare cases, metastasis. Surgical management is the primary treatment and includes intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Deventer, Niklas, Deventer, Nils, Gosheger, Georg, de Vaal, Marieke, Budny, Tymoteusz, Laufer, Andrea, Heitkoetter, Birthe, Luebben, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750402/
https://www.ncbi.nlm.nih.gov/pubmed/33364155
http://dx.doi.org/10.1016/j.jbo.2020.100342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750402/
https://www.ncbi.nlm.nih.gov/pubmed/33364155
http://dx.doi.org/10.1016/j.jbo.2020.100342

Ejemplares similares